相关实验视频

Updated: Jul 4, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

左前庭尾阻塞和手术后的抗血栓管理

Anders Kramer¹, Giuseppe Patti^2,3, Jens Erik Nielsen-Kudsk¹

¹Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus, Denmark.

Journal of clinical medicine

|February 10, 2024

概括

左心房尾阻塞 (LAAO) 防止心房动中风. 术后的抗血栓治疗对于预防器械相关血栓形成 (DRT) 是至关重要的,尽管最佳治疗方案仍然是可变的.

科学领域:

心脏病学心脏病学
医疗器械医疗器械
血栓形成研究研究

背景情况:

左心房尾阻塞 (LAAO) 为心房动中预防中风提供了抗凝药的替代方案.
手术后的抗血栓治疗是标准的,以减轻与设备相关的血栓形成 (DRT) 风险.
在LAAO之后,目前的抗血栓策略表现出显著的国际和中心间的变化.

研究的目的:

审查LAAO后对抗血栓治疗的现有证据.
讨论正在进行的随机试验,调查术后管理.
探索未来的DRT风险管理方向.

主要方法:

对当前抗血栓治疗方案的文献综述.
从临床研究和动物模型中分析数据.
目前正在进行的随机对照试验的概述.

主要成果:

没有确定LAAO后抗血栓治疗的最佳持续时间和类型.
在植入后的最初45-90天内,DRT风险最高.
临床实践的变化凸显了对标准化指导方针的需求.

结论:

对LAAO后的抗血栓治疗需要基于证据的指导方针.
目前正在进行的试验对于确定最佳治疗策略至关重要.
未来的研究应该专注于个性化的抗血栓治疗方法,以尽量减少DRT.

关键词:

这是一种抗凝血药物.这是一种抗血小板药物,抗血小板药物.心房动是心房动的一种.缺血性中风中风左心房附属体的封闭性闭塞

更多相关视频

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Robotic Ablation of Atrial Fibrillation

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...